Business Description
![Spexis AG Spexis AG logo](https://static.gurufocus.com/logos/0C0000BFS7.png?14)
Spexis AG
ISIN : CH0106213793
Share Class Description:
CHIX:SPEXz: Registered SharesCompare
Compare
Traded in other countries / regions
SPEX.SwitzerlandSPEXz.UK29Y.GermanyPPHOF.USA IPO Date
2018-05-16Description
Spexis AG is a clinical-stage biopharmaceutical company. The company is engaged in the discovery and development of antibiotics and other specialty pharma products for severe or life-threatening diseases. The company's lead product, murepavadin, is in Phase III development against Pseudomonas aeruginosa - recognized as a critical priority 1 pathogen by World Health Organization. It has one operating segment focusing on the research and development and prospective commercialization of respiratory therapeutics addressing high unmet medical needs.
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.05 | |||||
Equity-to-Asset | 0.14 | |||||
Debt-to-Equity | 3.64 | |||||
Debt-to-EBITDA | -0.47 | |||||
Piotroski F-Score | 1/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -55.7 | |||||
3-Year EPS without NRI Growth Rate | -38.1 | |||||
3-Year FCF Growth Rate | -17.2 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 87.61 | |||||
9-Day RSI | 80.52 | |||||
14-Day RSI | 75.97 | |||||
6-1 Month Momentum % | 48.72 | |||||
12-1 Month Momentum % | -82.02 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.38 | |||||
Quick Ratio | 0.38 | |||||
Cash Ratio | 0.05 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -73.9 | |||||
Shareholder Yield % | -58.54 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -151.03 | |||||
ROA % | -77.04 | |||||
ROIC % | -79.3 | |||||
ROC (Joel Greenblatt) % | -1603.23 | |||||
ROCE % | -100.28 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 1.84 | |||||
EV-to-EBIT | -0.83 | |||||
EV-to-EBITDA | -0.86 | |||||
EV-to-FCF | -1.93 | |||||
Earnings Yield (Greenblatt) % | -120.63 | |||||
FCF Yield % | -73.29 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Spexis AG Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil CHF) | |||
EPS (TTM) (CHF) | 0 | ||
Beta | -5.4 | ||
Volatility % | 681.39 | ||
14-Day RSI | 75.97 | ||
14-Day ATR (CHF) | 0.008886 | ||
20-Day SMA (CHF) | 0.06703 | ||
12-1 Month Momentum % | -82.02 | ||
52-Week Range (CHF) | 0.0314 - 0.397 | ||
Shares Outstanding (Mil) | 67.66 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 1 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Spexis AG Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Spexis AG Stock Events
Event | Date | Price(CHF) | ||
---|---|---|---|---|
No Event Data |
Spexis AG Frequently Asked Questions
What is Spexis AG(CHIX:SPEXz)'s stock price today?
The current price of CHIX:SPEXz is CHF0.12. The 52 week high of CHIX:SPEXz is CHF0.40 and 52 week low is CHF0.03.
When is next earnings date of Spexis AG(CHIX:SPEXz)?
The next earnings date of Spexis AG(CHIX:SPEXz) is .
Does Spexis AG(CHIX:SPEXz) pay dividends? If so, how much?
Spexis AG(CHIX:SPEXz) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |